Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers
Apply
Telisotuzumab Adizutecan, Gemcitabine, Nab-Paclitaxel
A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step